Best AI Prompts for Stock Analysis

Conduct a deep-dive analysis of this company's latest 10-K or 10-Q filing. Company: [Ticker / Company Name] Filing Period: [e.g. FY 2025 10-K or Q2 2026 10-Q] Key financial metrics: [Revenue, Gross Margin, Net Income, Free Cash Flow if known] Analyze and summarize: 1. Revenue Growth Drivers: Organic vs. acquisition-driven, product line breakdown, and geographic exposure 2. Margin Trajectory: Gross, operating, and net margin trends over the past 3-5 years 3. Balance Sheet Quality: Cash vs. total debt, debt maturity profile, and net working capital trends 4. Cash Flow Realism: Free Cash Flow vs. Net Income (flag high SBC or working capital distortions) 5. Risk Factors: Top 3 operational or regulatory risks disclosed in Item 1A Conclude with 3 critical questions management needs to answer on the next call.

Evaluate the competitive advantage and economic moat of this company using Morningstar's moat framework and Porter's Five Forces. Company: [Company / Ticker] Industry: [e.g. Cloud Infrastructure, Semiconductor Equipment, Enterprise SaaS] Main Competitors: [list 2-4 competitors] Assess each potential moat source: 1. Network Effects: Does the platform become more valuable with scale? 2. Switching Costs: How painful and expensive is it for enterprise customers to migrate away? 3. Cost Advantage: Proprietary processes, scale efficiencies, or unique supply assets? 4. Intangible Assets: Patents, regulatory licenses, or pricing power brand equity? 5. Efficient Scale: Is the market niche protected from rational new entrants? Rate the moat: None / Narrow / Wide with a 2-3 sentence justification and identify the #1 threat that could erode this moat over the next decade.

Analyze management's capital allocation track record and Return on Invested Capital (ROIC). Company: [Company / Ticker] Past 3-5 Years Data: - ROIC / ROCE: [numbers or approximate] - WACC: [if estimated] - CapEx: [growth vs. maintenance if known] - M&A history: [key acquisitions] - Share repurchases & dividends: [amounts] Evaluate: 1. Value Creation Spread: Is ROIC sustainably above WACC? What drives the spread? 2. Organic Reinvestment: Are reinvested dollars compounding at high marginal rates of return? 3. M&A Discipline: Have past acquisitions created shareholder value or resulted in goodwill impairments? 4. Shareholder Returns: Are buybacks executed opportunistically below intrinsic value, or merely offsetting dilution from stock-based compensation? 5. Final Score: Grade capital allocation (A to F) with key supporting evidence.

Evaluate the working capital efficiency and cash conversion cycle of this company. Company: [Company / Ticker] Metrics (if available): - Days Sales Outstanding (DSO): [days] - Days Inventory Outstanding (DIO): [days] - Days Payables Outstanding (DPO): [days] - Free Cash Flow Conversion (% of EBITDA or Net Income): [%] Analyze: 1. Cash Conversion Cycle (CCC = DSO + DIO - DPO): Calculate or interpret trend over the last 3 years 2. Working Capital Quality: Are receivables growing faster than revenue (channel stuffing warning)? Is inventory piling up? 3. Supplier Leverage: Is DPO extending at the expense of vendor relationships, or reflecting genuine bargaining power? 4. Cash Drag / Generation: Is working capital a source of cash or a perpetual drain as the business scales? 5. Benchmark: Compare these working capital dynamics to 2 direct competitors.

Help me build realistic, defendable assumptions for a 5-year Discounted Cash Flow (DCF) model. Company: [Company Name / Ticker] Current Stock Price: $[Price] Current Revenue: $[Revenue] Trailing Free Cash Flow: $[FCF] Industry: [Industry] Draft a 3-scenario assumption matrix (Bear / Base / Bull): 1. Revenue CAGR (Years 1-5): Justify rates based on TAM expansion and market share 2. Terminal FCF Margin: Expected operating leverage and steady-state CapEx needs 3. WACC / Discount Rate: Beta, cost of equity, and after-tax cost of debt 4. Terminal Growth Rate: Long-term GDP / inflation proxy (typically 2-3%) 5. Enterprise Value to Equity Value Bridge: Net debt adjustment, minority interest, and diluted shares Calculate implied share price for each scenario and show which variable is most sensitive to changes.

Conduct a relative valuation multiples analysis comparing this target company against its closest peer group. Target Company: [Ticker] Peers: [Peer 1, Peer 2, Peer 3, Peer 4] Metrics: - EV / NTM Revenue: [Target vs Peers] - EV / NTM EBITDA: [Target vs Peers] - P / E (Forward): [Target vs Peers] - PEG Ratio: [Target vs Peers] - Rule of 40 / Growth Rate: [Growth + FCF Margin] Deliver: 1. Valuation Matrix: Table ranking target vs peers across each multiple 2. Premium / Discount Justification: Is the target trading at a premium or discount? Is it justified by growth, margins, or ROIC? 3. Normalized Multiple: What multiple should this business trade at under steady-state conditions? 4. Target Price Range: Implied share price based on peer median multiples.

Perform a reverse DCF to uncover what growth and profitability assumptions are currently priced into this stock. Company: [Ticker] Current Market Cap / Enterprise Value: $[Value] Current Share Price: $[Price] Current Free Cash Flow: $[FCF] Assumed Discount Rate (WACC): [e.g. 9% or 10%] Terminal Growth Rate: [e.g. 2.5%] Determine: 1. Implied FCF Growth: What 5-year or 10-year FCF compound growth rate is required to justify today's price? 2. Operational Translation: What does that FCF growth require in terms of revenue CAGR and operating margin expansion? 3. Market Share Reality Check: Given total addressable market (TAM), is that implied revenue growth realistic, aggressive, or conservative? 4. Asymmetric Verdict: Does the current market price offer a margin of safety, or is it priced for perfection?

Assess the safety, growth runway, and sustainability of this company's dividend payout. Company: [Company / Ticker] Current Dividend Yield: [%] Annual Payout per Share: $[Amount] Free Cash Flow per Share: $[Amount] EPS: $[Amount] Net Debt / EBITDA: [Ratio] Evaluate: 1. FCF Payout Ratio: Dividends paid as a % of FCF (is it below 60-70% comfort threshold?) 2. Accounting EPS vs. Cash Payout: Are dividends covered by true cash generation or debt? 3. Balance Sheet Leverage: Will debt maturities or refinancing threaten the dividend in a downturn? 4. Dividend Growth History: 3, 5, and 10-year dividend growth CAGR 5. Stress Test: If revenue drops 15% and margins contract 300 bps, can management maintain the dividend? Rating: Safe / Vulnerable / At-Risk of Cut with specific triggers to monitor.

Analyze this earnings call transcript or summary to extract the signal from the noise. Company: [Company Name / Ticker] Quarter: [e.g. Q4 2025 / Q1 2026] Transcript text or key highlights: [paste key remarks from CEO/CFO and analyst Q&A] Provide: 1. Management Key Messages: What did leadership emphasize in prepared remarks? 2. Analyst Pressure Points: What specific questions did analysts push hardest on during Q&A? 3. Evasive or Defensive Answers: Where did management give vague, non-committal, or deflecting responses? 4. Hidden Guidance Clues: Did commentary hint at headwinds, supply bottlenecks, or decelerating enterprise sales cycles? 5. Three-sentence takeaway for an investor.

Analyze this company's newly released quarterly guidance versus Wall Street consensus expectations. Company: [Ticker] Quarter / Year Being Guided: [e.g. Q2 2026 / FY 2026] Reported Guidance: - Revenue: [Range] - Gross Margin / Operating Margin: [Range] - EPS / Adjusted EBITDA: [Range] Wall Street Consensus: - Expected Revenue: [Consensus] - Expected EPS: [Consensus] Deliver: 1. Beat / Meet / Miss Summary: Quantify percentage variance for both current quarter and forward outlook 2. Guidance Quality: Is growth front-loaded or back-half weighted (the classic 'hockey-stick' risk)? 3. Operating Leverage Check: Is revenue guiding higher while EPS guides lower (margin compression signal)? 4. Implied Estimate Revisions: How will sell-side analysts likely adjust their price targets and models following this release?

Review the earnings surprise history and post-earnings stock price volatility for this company. Company: [Ticker] Past 4-8 Quarters Data: - EPS Beats / Misses: [list quarters] - Revenue Beats / Misses: [list quarters] - Average Next-Day Price Reaction (%): [e.g. +/- 6%] - Implied Options Move for Upcoming Earnings: [if known] Analyze: 1. Consistency Pattern: Does management sandbag guidance and consistently beat by a predictable percentage? 2. Reaction Asymmetry: Does the stock sell off sharply on modest beats (priced for perfection) or rally on relief? 3. Earnings Quality: Are beats driven by revenue outperformance or below-the-line items (tax rate, share count, FX)? 4. Risk Management: What position size or hedging strategy is prudent going into the upcoming print?

Compare management's language and tone across the last two consecutive quarters to spot shifts in sentiment. Company: [Ticker] Quarter A (Previous Quarter) notes: [paste quotes or key statements] Quarter B (Current Quarter) notes: [paste quotes or key statements] Identify: 1. Tone Trajectory: Is management becoming more cautious, confident, defensive, or promotional? 2. Vocabulary Shift: Track changes in words like 'headwind', 'uncertainty', 'elongated sales cycles', vs. 'tailwind', 'acceleration', 'robust pipeline' 3. Metric Substitution: Did management stop mentioning a previously touted KPI (customer count, net retention rate, backlog)? 4. Capital Allocation Tone: Any change in rhetoric regarding buybacks, debt repayment, or CapEx? 5. Net Sentiment Score: Bullish / Neutral / Bearish shift summary.

Map out the technical structure, trend alignment, and key price levels for this stock across multiple timeframes. Stock Ticker: [Ticker] Current Price: $[Price] Weekly Chart Context: [e.g. 52-week high/low, 200-week SMA, macro trend] Daily Chart Context: [e.g. 50-day and 200-day SMA, current pattern like cup-and-handle, flag, or breakdown] Key indicators: [RSI, MACD, Volume Profile if observed] Provide: 1. Primary Trend: Bullish, Bearish, or Consolidation on Weekly vs. Daily 2. Key Resistance Levels: List 3 overhead price zones where sellers are likely clustered 3. Key Support Levels: List 3 support floors (prior breakout pivots, moving average confluences) 4. Moving Average Health: Position relative to 20/50/200 SMA (e.g. Golden Cross, Death Cross, extended above 20 SMA) 5. Setup Summary: Best risk-defined entry price, invalidation stop-loss level, and initial target.

Calculate the asymmetric risk-to-reward ratio and optimal position size for this stock trade/investment. Total Portfolio Value: $[Amount, e.g. 100,000] Max Risk Tolerance per Trade: [e.g. 1% or 2% of total portfolio = $1,000] Target Entry Price: $[Entry] Technical / Fundamental Stop Loss: $[Stop Price] Target Price 1 (Conservative): $[Target 1] Target Price 2 (Bull Case): $[Target 2] Calculate and outline: 1. Per-Share Risk: Entry - Stop Loss ($ and %) 2. Position Sizing: Number of shares to purchase so total dollar loss at stop equals maximum allowed risk 3. Total Capital Allocation: Total dollar commitment and what % of total portfolio it represents 4. Risk-to-Reward Ratio: Calculate R:R for Target 1 and Target 2 (flag if under 3:1) 5. Profit Taking & Trimming Strategy: Scale-out plan (e.g. sell 1/3 at Target 1, trail stop to breakeven).

Audit the short interest dynamics, borrowing costs, and short squeeze potential for this stock. Company: [Ticker] Short Interest (% of Float): [%] Days to Cover (Short Interest Ratio): [Days] Borrow Fee / Cost to Borrow: [%] Institutional Ownership (%): [%] Retail / Social Sentiment: [High / Moderate / Low] Analyze: 1. Squeeze Vulnerability Score (1-10): Based on float size, borrow fee spikes, and days to cover 2. The Short Thesis: Why are institutional funds heavily shorting this company? What is their core bear argument? 3. Catalyst Potential: What upcoming announcement (earnings, FDA approval, contract win, activist letter) could force shorts to cover? 4. Borrow Availability: Is borrow tightening or becoming prohibitively expensive? 5. Risk Warning: If initiating a short or long position, what asymmetric risks and borrow fee traps must be hedged?

Analyze volume behavior to detect whether institutional 'smart money' is accumulating or distributing shares. Stock: [Ticker] Recent Price Action: [e.g. consolidating between $140 and $150 after an earnings gap] Volume Characteristics: - Up-day volume vs. Down-day volume: [e.g. heavy volume on green days, dry volume on pullbacks] - Recent block trades / dark pool activity: [if observed] - On-Balance Volume (OBV) trend: [rising, flat, falling] Evaluate: 1. Accumulation vs. Distribution: Are institutions quietly absorbing shares at key price floors? 2. Volume Dry-Up: Is volume contracting significantly during pullbacks into moving averages (bullish absorption sign)? 3. Climax Volume Signals: Any evidence of selling exhaustion or buying capitulation? 4. Point of Control (POC): Estimated highest volume node where most trading has occurred 5. Actionable Takeaway: Does volume support initiating a position here, or does it signal institutional exit?

Assess how this company performs across different macroeconomic regimes and business cycles. Company / Sector: [Company / Sector, e.g. Industrial Automation, Luxury Retail, Regional Banks] Current Macro Backdrop: - Interest Rate Trend: [rising / pausing / cutting] - Inflation & Wage Pressures: [elevated / cooling] - Consumer Sentiment & Credit Delinquencies: [strong / weakening] - GDP / Purchasing Managers Index (PMI): [expansion >50 / contraction <50] Analyze: 1. Cyclical vs. Secular Growth: How much of recent growth was cyclical macro tailwinds vs. secular structural adoption? 2. Interest Rate Sensitivity: Impact of higher-for-longer rates on debt refinancing and customer purchasing decisions 3. Pricing Power in Inflation: Can the company pass on rising input costs without destroying unit volumes? 4. Recession Playbook: How did revenue and operating margins fare during 2008 and 2020? 5. Cyclical Peak / Trough Verdict: Is this sector closer to peak cycle or trough cycle valuation?

Audit customer concentration and geopolitical supply chain dependencies for this business. Company: [Company / Ticker] Customer Exposure: - Top Customer Revenue %: [e.g. Customer A accounts for 18% of revenue] - Top 5/10 Customers %: [if disclosed in 10-K] Supply Chain Notes: - Key suppliers / foundries / manufacturing partners: [e.g. TSMC, Foxconn, single-source vendors] - Geographic manufacturing distribution: [e.g. 70% manufactured in Taiwan/China] Deliver: 1. Concentration Risk Score: High / Medium / Low with revenue loss impact if top customer defects 2. Single-Point-of-Failure Audit: Are critical components or manufacturing steps tied to a single supplier or geographic choke point? 3. Geopolitical Exposure: Tariffs, export controls, and foreign exchange exposure vulnerabilities 4. Mitigation Trajectory: Is management actively diversifying suppliers and customers, and what will it cost in CapEx/margins?

Analyze pending regulatory scrutiny, antitrust litigation, and public policy changes affecting this stock. Company: [Ticker / Sector] Regulatory Bodies Involved: [e.g. FTC, DOJ, European Commission, SEC, FDA, EPA] Pending Inquiries / Legislation: [describe lawsuits, proposed tariffs, or antitrust investigations] Evaluate: 1. Worst-Case Legal Outcome: Fines, forced breakups, structural business model remedies, or product bans 2. Revenue at Risk: What percentage of total revenue or high-margin services is directly tied to the contested business practice? 3. Precedent Cases: How have similar regulatory challenges been resolved for industry peers? 4. Competitive Impact: Would aggressive regulation create higher compliance barriers to entry that inadvertently protect the incumbent? 5. Probability-Weighted Financial Impact: Estimate potential penalty and EPS impact over the next 1-3 years.

Create a head-to-head benchmark matrix comparing this company with its two primary rivals. Target Company: [Company A] Rival 1: [Company B] Rival 2: [Company C] Compare across 6 dimensions: 1. Revenue Growth & Scale: Trailing growth and absolute revenue base 2. Margin Profile: Gross margin, operating margin, and FCF margin efficiency 3. Unit Economics / Monetization: ARPU, Net Revenue Retention (NRR), or gross profit per unit 4. R&D & Innovation: R&D spending as a % of revenue and patent/product velocity 5. Balance Sheet Strength: Net cash position, debt-to-equity, and credit rating 6. Valuation Multiples: P/E, EV/Sales, EV/EBITDA Conclude with: Which company possesses the highest quality-to-valuation score, and why?

Construct a rigorous institutional-grade Bull vs. Bear debate for this stock. Company: [Company / Ticker] Current Valuation / Price: $[Price, Multiples] Core Business Summary: [1-2 sentences on what they sell] Develop: The Bull Case (3 Core Pillars): 1. Primary growth catalyst and TAM expansion opportunity 2. Operating leverage and margin expansion path 3. Why current valuation underappreciates future earnings power The Bear Case (3 Core Pillars): 1. Primary competitive, macro, or structural risk 2. Margin contraction or commoditization threat 3. Why consensus estimates are overly optimistic Critical Swing Factor: What single metric or milestone over the next 12 months will prove which side is right?

Conduct an investment pre-mortem: Imagine it is 3 years from today, and this stock has lost 50% of its value. Tell the story of what went wrong. Company: [Company / Ticker] My Current Thesis: [why I want to buy / invest in it] Current Bullish Assumptions: [growth rate, competitive moat, management execution] Detail the exact failure narrative: 1. The Blind Spot: What critical risk did the market and bull consensus completely overlook or dismiss? 2. Competitive Erosion: Did a rival, open-source alternative, or hyperscaler disrupt their core pricing power? 3. Capital Allocation Disaster: Did an overpriced acquisition, reckless share buybacks, or debt expansion destroy the balance sheet? 4. Multiple Compression: Even if earnings grew modestly, why did the market re-rate the multiple from 30x to 15x? 5. Key Warning Signs: 3 early warning indicators that would have alerted an observant investor in Year 1.

Draft a concise, high-conviction one-page investment memo for this stock pitch. Company: [Company / Ticker] Current Price: $[Price] | Market Cap: $[Cap] Target Horizon: [e.g. 1-3 years] Structure the memo: 1. Executive Summary: What does the company do and why is it mispriced by the market today? (3 sentences) 2. The Variant Perception: What do you believe that the consensus Wall Street view is missing or getting wrong? 3. Financial Engine: Revenue growth driver, unit economics, and FCF generation profile 4. Valuation & Target Price: Base case price target with expected IRR / upside percentage 5. Key Catalysts: 2-3 specific milestones over the next 12-18 months that will unlock value 6. Kill Criteria: Under what specific conditions will you sell and admit the thesis is invalidated?

Define an explicit exit strategy, profit-taking rules, and thesis invalidation triggers before entering this position. Company: [Company / Ticker] Entry Price: $[Price] Target Valuation: $[Target Price] Original Thesis Core Points: [list 2-3 reasons for buying] Create a disciplined exit ruleset: 1. Profit-Taking Protocol: At what price or valuation multiple will you trim 33%, 50%, or exit completely? 2. Fundamental Invalidation Triggers: List 3 specific operational breakdowns (e.g. NRR drops below 110%, operating margin drops 2 quarters in a row, founder leaves) that trigger an immediate sale regardless of stock price 3. Opportunity Cost Threshold: When does another asset present a significantly better risk/reward justifying reallocating this capital? 4. Emotional Guardrail: What rule will prevent you from averaging down on a broken fundamental story?